Rapidly evolving skin manifestations due to progressive thrombosis in a patient with paroxysmal nocturnal haemoglobinuria resolved with prompt initiation of eculizumab

British Journal of Dermatology

Volumn 171, Issue 4, 2014, Pages 908-910

  Otters, E F M ^a   Zarafonitis, G ^a   Steenbergen, E J ^a   Van Der Valk, P G M ^a   Muus, P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; D DIMER; ECULIZUMAB; FERROUS FUMARATE; FOLIC ACID; HEMOGLOBIN; LACTATE DEHYDROGENASE; FIBRINOLYTIC AGENT; MONOCLONAL ANTIBODY;

ADULT; CASE REPORT; ECCHYMOSIS; ERYTHEMA INFECTIOSUM; FATIGUE; FEMALE; FEVER; GRANULOCYTE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN PARVOVIRUS B19; INTERNATIONAL NORMALIZED RATIO; LETTER; LEUCOCYTOCLASIA; LEUKOCYTE DISORDER; MYALGIA; NEUTROPHIL CHEMOTAXIS; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RASH; SEROLOGY; SKIN BIOPSY; SKIN MANIFESTATION; SKIN THROMBOSIS; THROMBOCYTE COUNT; THROMBOSIS; COMPLICATION; EXANTHEMA; SKIN DISEASES, VASCULAR;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; EXANTHEMA; FEMALE; FIBRINOLYTIC AGENTS; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; SKIN DISEASES, VASCULAR; THROMBOSIS;

EID: 84936087095     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.13033     Document Type: Letter

References (12)

1. Takeda J, Miyata T, Kawagoe K, et al,. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 1993; 73: 703-11.
2. Holguin MH, Wilcox LA, Bernshaw NJ, et al,. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 1989; 84: 1387-94.
3. Van Bijnen STA, Van Heerde WL, Muus P,. Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria. J Thromb Haemost 2012; 10: 1-10.
4. Hill A, Kelly RJ, Hillmen P,. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 2013; 121: 4985-96.
5. Ziakas PD, Poulou LS, Rokas GI, et al,. Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks, outcome. An overview. J Thromb Haemost 2007; 5: 642-5.
6. Cholez C, Schmutz JL, Hulin C, et al,. Cutaneous necrosis during paroxysmal nocturnal haemoglobinuria: role of parvovirus B19? J Eur Acad Dermatol Venereol 2005; 19: 380-99.
7. Schutgens RE, Pruissen-Peeters KA, Muus P,. A cascade of thromboembolic processes in a patient with paroxysmal nocturnal haemoglobinuria terminated by treatment with eculizumab. J Thromb Haemost 2011; 106: 383-5.
8. Nagase K, Okawa T, Otsu M, et al,. Extensive cutaneous ulcerations and necrosis associated with paroxysmal nocturnal hemoglobinuria. Arch Dermatol 2012; 148: 660-2.
9. White JML, Watson K, Arya R, et al,. Haemorrhagic bullae in a case of paroxysmal nocturnal haemoglobinuria. Clin Exp Dermatol 2003; 28: 504-5.
10. Watt SG, Winhoven S, Hay CRM, et al,. Purpural fulminans in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2007; 137: 271-3.
11. Hall C, Richards S, Hillmen P,. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 2003; 102: 3587-91.
12. Brodsky RA,. How I treat paroxysmal nocturnal hemoglobinuria. Blood 2009; 113: 6522-7.